Intels results could be affected by adverse effects associated with product defects and errata (deviations frompublished specifications), and by litigation or regulatory matters involving intellectualproperty, stockholder, consumer, antitrust, disclosure and other issues, such as the litigation and regulatory matters described inIntels SEC reports.